2002 - Fellow of American Physical Society (APS) Citation For pioneering work in the development and construction of 3rd generation synchrotron radiation sources
Alan Jackson mainly focuses on Pathology, Magnetic resonance imaging, Internal medicine, Nuclear medicine and Radiology. The concepts of his Pathology study are interwoven with issues in Angiogenesis, Central nervous system, Abnormality, Perfusion scanning and In vivo. His research integrates issues of Neovascularization, Molecular imaging, Clinical trial and Perfusion in his study of Magnetic resonance imaging.
His Internal medicine research includes elements of Gastroenterology, Endocrinology, Hyperintensity and Oncology. Alan Jackson interconnects Dynamic contrast-enhanced MRI, Orbit, Enophthalmos, Glioma and Blood volume in the investigation of issues within Nuclear medicine. His studies deal with areas such as Cause of death, Artery, Sudden death and Autopsy as well as Radiology.
Alan Jackson mainly investigates Pathology, Magnetic resonance imaging, Internal medicine, Rabies and Virology. His Pathology research includes themes of Angiogenesis, Central nervous system disease and Glioma. His Magnetic resonance imaging research is multidisciplinary, relying on both Nuclear medicine and Perfusion.
His Internal medicine research incorporates elements of White matter, Hyperintensity, Oncology, Cardiology and Depression. The Rabies study combines topics in areas such as Encephalitis, Disease and Immunology. His work deals with themes such as Encephalomyelitis and Central nervous system, which intersect with Virology.
His main research concerns Internal medicine, Nuclear medicine, Oncology, Rabies and Magnetic resonance imaging. Alan Jackson has included themes like Cognition, Depression and Cardiology in his Internal medicine study. His work carried out in the field of Nuclear medicine brings together such families of science as Vestibular system, Schwannoma, Confidence interval, Repeatability and Reproducibility.
His Rabies research is multidisciplinary, incorporating elements of Transmission, Encephalitis and Immunology. His studies in Magnetic resonance imaging integrate themes in fields like Glioma and Pathology. His Pathology study integrates concerns from other disciplines, such as Vascular endothelial growth factor and In vivo.
Alan Jackson spends much of his time researching Internal medicine, Pathology, Oncology, Magnetic resonance imaging and Rabies. His work carried out in the field of Internal medicine brings together such families of science as Anesthesia and Cardiology. Alan Jackson is interested in Immunohistochemistry, which is a field of Pathology.
His Oncology study combines topics from a wide range of disciplines, such as Biomarker, Neurocognitive, Recurrent glioblastoma and Temozolomide. His research integrates issues of Hypoxia, Radiation therapy, Tumor hypoxia, Glioma and In vivo in his study of Magnetic resonance imaging. Alan Jackson has researched Rabies in several fields, including Virus, Encephalitis and Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI.
Geoffrey James Parker;Caleb Roberts;Andrew Macdonald;Giovanni A Buonaccorsi.
Magnetic Resonance in Medicine (2006)
DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents
James P B O'Connor;Alan Jackson;Geoff J M Parker;Gordon C Jayson.
British Journal of Cancer (2007)
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations
Martin O Leach;K Brindle;J Evelhoch;John R Griffiths.
British Journal of Cancer (2005)
Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial
Ian Gilron;Ian Gilron;Joan M Bailey;Joan M Bailey;Dongsheng Tu;Ronald R Holden.
The Lancet (2009)
Post-mortem imaging as an alternative to autopsy in the diagnosis of adult deaths: a validation study
Ian S D Roberts;Rachel E Benamore;Emyr W Benbow;Stephen H Lee.
The Lancet (2012)
Imaging biomarker roadmap for cancer studies.
James P.B. O'Connor;Eric O. Aboagye;Judith E. Adams;Hugo J.W.L. Aerts;Hugo J.W.L. Aerts.
Nature Reviews Clinical Oncology (2017)
Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome
James P.B. O'Connor;Chris J. Rose;John C. Waterton;Richard A.D. Carano.
Clinical Cancer Research (2015)
The hard side of change management
Harold L. Sirkin;Perry Keenan;Alan Jackson.
IEEE Engineering Management Review (2014)
Current status of rabies and prospects for elimination.
Anthony R Fooks;Ashley C Banyard;Daniel L Horton;Nicholas Johnson.
The Lancet (2014)
Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies
James P. B. O'Connor;Alan Jackson;Geoff J. M. Parker;Caleb Roberts.
Nature Reviews Clinical Oncology (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: